Article info
PDFA difficult case
Epstein–Barr virus associated CNS lymphoproliferative disorder after long-term immunosuppression
- Correspondence to Dr Clare M Galtrey, Neurology, Frimley Health NHS Foundation Trust, Camberley GU16 7UJ, UK; claregaltrey{at}nhs.net
Citation
Epstein–Barr virus associated CNS lymphoproliferative disorder after long-term immunosuppression
Publication history
- Accepted August 10, 2019
- First published August 29, 2019.
Online issue publication
July 02, 2020
Article Versions
- Previous version (14 January 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- HIV infection and lymphoma
- Successful treatment of central nervous system lymphoproliferative disorder in a kidney-pancreas and stem cell transplanted patient using intrathecal rituximab
- Primary CNS lymphoma in a patient treated with azathioprine
- Primary low-grade diffuse small lymphocytic lymphoma of the central nervous system
- Chronic inflammatory demyelinating polyneuropathy evolving to primary CNS lymphoma
- Cancers related to viral agents that have a direct role in carcinogenesis: pathological and diagnostic techniques
- Neurological consults on the renal unit
- Herpesvirus infection of eye and brain in HIV infected patients
- Epstein–Barr virus infection and central nervous system involvement after orthoptic liver transplant
- A longitudinally extensive myelopathy in a patient with AIDS